1 asset in Mucopolysaccharidosis Type 4A

Therapeutic assets addressing Mucopolysaccharidosis Type 4A, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Mucopolysaccharidosis Type 4A	University of California, San Francisco	P1	CC (43)